GRP
NMTR

Global Retirement Partners’s 9 Meters Biopharma NMTR Stock Holding History

Global Retirement Partners’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1
Closed – – 1757
2020
Q1 		$0 Buy
+1
New +$13 ﹤0.01% 1714

Other funds holding NMTR

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Global Retirement Partners's NMTR Position: Q2 2020 in Review

Global Retirement Partners sold out of 9 Meters Biopharma (NMTR) in Q2 2020, closing a stake of 1 share.

Global Retirement Partners first reported a position in NMTR in Q1 2020 and held it in 1 quarter. The position peaked at $0 in Q1 2020. 26 funds tracked by Wall St. Rank hold NMTR as of Q2 2020.

  • Global Retirement Partners reported no remaining 9 Meters Biopharma position as of Q2 2020 after selling out during the quarter.
  • Global Retirement Partners sold 1 9 Meters Biopharma share in Q2 2020.
  • Global Retirement Partners first reported a position in 9 Meters Biopharma in Q1 2020 and held it in 1 quarter.
  • Global Retirement Partners's 9 Meters Biopharma position peaked at $0 in Q1 2020.
  • 26 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2020.

Based on Global Retirement Partners's 13F filing for Q2 2020, filed 13 Jul 2020.